Current Month 2013
Article Features
  2 Views Are Better Than 1 in 3-D Breast Screening
Analysis Identifies Prognostic RNA Markers in a Common Form of Breast Cancer
Coffee May Help Prevent Breast Cancer From Returning, Study Finds
Cold Winters Freezing Out Breast Cancer Treatment
Commonly Used Drug Can Limit Radiation Damage to Lungs and Heart for Cancer Patients
Few Breast Cancer Survivors Maintain Adequate Physical Activity Despite Benefits
How Does Pregnancy Reduce Breast Cancer Risk?
Intensity Modulated Radiotherapy Reduces Side Effects in Patients with Early Breast Cancer
Mammogram Rate Did Not Decline After Controversial USPSTF Recommendations
Mammograms Reveal Response to Tamoxifen
Metastasis Stem Cells in the Blood of Breast Cancer Patients Discovered
Microwave Imaging Can See How Well Treatment is Progressing
New Agent Might Control Breast Cancer Growth and Spread
New Computational Model Can Predict Breast Cancer Survival
Novel Monoclonal Antibody Inhibits Tumor Growth in Breast Cancer and Angiosarcoma
Researchers Identify New Pathway, Enhancing Tamoxifen to Tame Aggressive Breast Cancer
Same Protein That Fires Up Cancer-Promoting Erk Also Blocks Its Activation
Screening Breast Ultrasound Detects Cancers Missed on Mammography in Women with Dense Breasts
Study Finds Scientific Basis for Cognitive Complaints of Breast Cancer Patients
Tomosynthesis Increases Breast Cancer Detection Rate


Screening Breast Ultrasound Detects Cancers Missed on Mammography in Women with Dense Breasts

Screening breast ultrasound performed after mammography on women with greater than 50% breast density detects an additional 3.4 cancers or high risk lesions per one thousand woman screened, a detection rate just under that of screening mammography alone for women with less dense breasts, a new study shows. Screening mammography detects 4-5 cancers per thousand women screened.

The study, conducted in conjunction with seven Connecticut radiology practices, included 19,745 women who had dense breasts and "normal" mammograms. Sixty-seven cancers were found, said Dr. Sarah Steenbergen, lead author of the study, who is now at Yale University in New Haven, CT. "Out of the available surgical reports, only one case had nodal involvement at the time of diagnosis. This suggests that the cancers are detected early and therefore we anticipate a survival benefit," Steenbergen said.

The study has been conducted over two years, "and we've seen an improvement in the sensitivity of screening breast ultrasound from 96.6% to 100% and in specificity from 94.0% to 96% from the first to the second year," she said. This illustrates a learning curve, and "we anticipate that as the number of screening breast ultrasounds increase, physicians will be even better able to differentiate benign from malignant lesions," she said.

Read More of the Main Article

 
Visit the Ezine


Visit the BreastCenter

Visit the Quality Corner
Avon Breast Cancer Crusade - AVON the company for women

  This website is supported in part by an unrestricted educational grant provided by Avon